These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21372030)

  • 1. Cancer chemoprevention--the cardiovascular model.
    Temple R
    Cancer Prev Res (Phila); 2011 Mar; 4(3):307-10. PubMed ID: 21372030
    [No Abstract]   [Full Text] [Related]  

  • 2. Food extracts for chemoprevention: quo vadis?
    Meyskens FL
    Cancer Prev Res (Phila); 2009 Jul; 2(7):608-10. PubMed ID: 19584073
    [No Abstract]   [Full Text] [Related]  

  • 3. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II.
    Moyad MA
    Urol Oncol; 2004; 22(6):472-7. PubMed ID: 15610864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I.
    Moyad MA
    Urol Oncol; 2004; 22(6):466-71. PubMed ID: 15610863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development.
    Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2038-41. PubMed ID: 17119025
    [No Abstract]   [Full Text] [Related]  

  • 6. Echocardiography's Role in Cardio-Oncology.
    Armour A
    J Am Soc Echocardiogr; 2018 Dec; 31(12):A28-A29. PubMed ID: 30522609
    [No Abstract]   [Full Text] [Related]  

  • 7. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-oncology: an ongoing evolution.
    Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
    Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive oncology--lessons from preventive cardiology.
    Neugut AI
    Lancet; 2004 Mar; 363(9414):1004-5. PubMed ID: 15051278
    [No Abstract]   [Full Text] [Related]  

  • 11. The discipline of onco-cardiology.
    Mouhayar E
    Future Oncol; 2015; 11(14):2027-9. PubMed ID: 26198831
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating asymptomatic chemotherapy-induced cardiac dysfunction: a chance that cardiologists and oncologists should not miss.
    Cardinale D; Colombo A; Cipolla CM
    J Am Coll Cardiol; 2011 Apr; 57(17):1790; author reply 1790-1. PubMed ID: 21511119
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention meets glucose control.
    Engelman JA; Cantley LC
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1049-52. PubMed ID: 20810671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical learning experiences of Israeli medical students in health promotion and prevention of cancer and cardiovascular diseases.
    Notzer N; Abramovitz R
    Isr Med Assoc J; 2002 Feb; 4(2):149-52. PubMed ID: 11875995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
    Jaussi A; Noll G; Meier B; Darioli R
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin chemoprevention: the long road to clinical translation.
    Shureiqi I; Baron JA
    Cancer Prev Res (Phila); 2011 Mar; 4(3):296-8. PubMed ID: 21372027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long- and short-range strategies in cancer prevention].
    Sidorenko IuS; Shaposhnikov AV
    Vopr Onkol; 2009; 55(6):671-8. PubMed ID: 20210007
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low high-density lipoprotein cholesterol and chronic disease risk marker or causal?
    Robinson JG
    J Am Coll Cardiol; 2010 Jun; 55(25):2855-7. PubMed ID: 20579543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.